Long-term effects of THC exposure on reward learning and motivated behavior in adolescent and adult male rats.

Abstract

Rationale

The endocannabinoid system makes critical contributions to reward processing, motivation, and behavioral control. Repeated exposure to THC or other cannabinoid drugs can cause persistent adaptions in the endocannabinoid system and associated neural circuitry. It remains unclear how such treatments affect the way rewards are processed and pursued.

Objective and methods

We examined if repeated THC exposure (5 mg/kg/day for 14 days) during adolescence or adulthood led to long-term changes in rats’ capacity to flexibly encode and use action-outcome associations for goal-directed decision making. Effects on hedonic feeding and progressive ratio responding were also assessed.

Results

THC exposure had no effect on rats’ ability to flexibly select actions following reward devaluation. However, instrumental contingency degradation learning, which involves avoiding an action that is unnecessary for reward delivery, was augmented in rats with a history of adult but not adolescent THC exposure. THC-exposed rats also displayed more vigorous instrumental behavior in this study, suggesting a motivational enhancement. A separate experiment found that while THC exposure had no effect on hedonic feeding behavior, it increased rats’ willingness to work for food on a progressive ratio schedule, an effect that was more pronounced when THC was administered to adults. Adolescent and adult THC exposure had opposing effects on the CB1 receptor dependence of progressive ratio performance, decreasing and increasing sensitivity to rimonabant-induced behavioral suppression, respectively.

Conclusions

Our findings reveal that exposure to a translationally relevant THC exposure regimen induces long-lasting, age-dependent alterations in cognitive and motivational processes that regulate the pursuit of rewards.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00213-023-06352-4.

Untitled section

Keywords: Cannabis, Marijuana, Addiction, Habit, Goal-directed action, Motivation, Emotion, Eating

Article notes

Untitled section

Received 2022 Dec 5; Accepted 2023 Mar 3; Issue date 2023.

Author notes

Introduction

Cannabis is widely viewed as being innocuous despite negatively impacting the lives of many of its users. Nearly a third of regular cannabis users meet the diagnostic criteria for cannabis use disorder (Hasin et al. 2015), indicating a pattern of intake that persists in spite of its adverse consequences. This is on par with estimates of heroin and cocaine use disorder among regular users of these drugs (Ferland and Hurd 2020), which is worrisome given the high and growing prevalence of regular cannabis use (Hammond et al. 2021; Yu et al. 2020). Individuals with cannabis use disorder also face a high risk of relapse when attempting to quit (Copeland et al. 2001; Moore and Budney 2003), as with other addictive drugs. Such findings highlight the need to advance understanding of how cannabis comes to exert such powerful control over behavior.

With repeated exposure, addictive drugs share a tendency to induce long-lasting behavioral and neural adaptations, and cannabis is no exception to this rule. Rats given repeated exposure to Δ⁹-tetrahydrocannabinol (THC), the main psychoactive component of cannabis, exhibit sensitization to the acute behavioral effects of this drug, as well as its ability to stimulate mesolimbic dopamine release (Cadoni et al. 2008). Some have argued that such adaptations reflect a fundamental change in motivational processing—termed incentive-sensitization—which fuels the addiction process by amplifying the desire to pursue drugs and other rewards (Berridge and Robinson 2016; Robinson and Berridge 1993).

An alternative view assumes that problematic, uncontrolled drug use reflects an underlying failure of adaptive, goal-directed decision making, which may be caused or exacerbated by repeated drug intake (Belin et al. 2013; Everitt and Robbins 2005; Ostlund and Balleine 2008). In line with this view, previous studies have shown that repeated exposure to various addictive drugs (Corbit et al. 2014; LeBlanc et al. 2013; Nelson and Killcross 2006, 2013; Nordquist et al. 2007; Renteria et al. 2018) including THC (Nazzaro et al. 2012) can promote the development inflexible reward-seeking habits (but see Ferland et al. 2022). Importantly, such effects are believed to reflect an acceleration in adaptive habit learning and need not involve a more wide-ranging impairment in goal-directed decision making or control (Ostlund and Balleine 2008). While the impact of repeated cannabinoid exposure on goal-directed control remains unclear, such treatments have been shown to cause long-lasting alterations in the structure and function of the prefrontal cortex (Cass et al. 2014; Renard et al. 2016; Rubino et al. 2015), a critical hub for goal-directed behavior (Balleine 2019; Bradfield and Hart 2020; Turner and Parkes 2020).

The endocannabinoid system undergoes profound changes during adolescence which are believed to help shape normal neurocognitive development but also make the brain more vulnerable to the harmful effects of cannabis and other drugs (Crews et al. 2007; Schneider 2008; Spear 2016; Stringfield and Torregrossa 2021a). Heavy adolescent cannabis use has been linked to later cognitive impairment and mental health problems (Chadwick et al. 2013; Levine et al. 2017; Lubman et al. 2015; Volkow et al. 2016). Likewise, animal studies have shown that adolescent exposure to cannabinoid drugs can cause persistent alterations in behavioral measures of emotion, motivation, and cognition (Bambico et al. 2010; Cha et al. 2007; Gleason et al. 2012; Higuera-Matas et al. 2015; Jacobs-Brichford et al. 2019; Kruse et al. 2019; O’Shea et al. 2004; Quinn et al. 2008; Realini et al. 2011; Renard et al. 2017; Rubino et al. 2008; Scherma et al. 2016; Schneider and Koch 2003; Schoch et al. 2018; Zamberletti et al. 2012), often having more pronounced effects than adult cannabinoid exposure (Quinn et al. 2008; Schneider and Koch 2003).

Research on the effects of cannabinoid exposure on reward-related behavior has produced mixed results that appear to depend on features of the drug exposure regimen (Stringfield and Torregrossa 2021a). For instance, long-term suppression of reward consumption and reward-motivated behavior has been observed following adolescent exposure to potent synthetic cannabinoids (Bambico et al. 2010) or high doses of THC (e.g., twice-daily injections of up to 10 mg/kg) (Realini et al. 2011; Rubino et al. 2008; Scherma et al. 2016). Such findings are notable because anhedonia—i.e., diminished interest in healthy, reward-seeking activities—is a common feature of depression, anxiety, and other psychiatric disorders (Husain and Roiser 2018). In contrast, repeated adolescent exposure to lower doses of THC (2.5–5 mg/kg/day) has often been seen to elevate, rather than suppress, reward-motivated behavior (Kruse et al. 2019; Orihuel et al. 2021). Further research on the effects of more moderate THC dosing regimens is therefore warranted, particularly given their relevance to modeling early-stage, cannabis use in humans (Poulia et al. 2021; Ruiz et al. 2021; Torrens et al. 2020).

The current study investigated the long-term consequences of an intermediate-dose THC regimen (5 mg/kg/day for 14 days) on reward-related behavior in male rats, using selective assays of emotion (hedonic feeding), motivation (effort exertion), and behavioral control (goal-directed decision making). Both adolescent- and adult-THC exposure conditions were included to investigate whether adolescent development exacerbates or otherwise alters the long-term behavioral effects of this treatment.

We also conducted a dose–response analysis of the behavioral effects of the inverse CB1 receptor agonist rimonabant on reward-motivated behavior in rats with or without a history of repeated THC exposure. Adolescent THC exposure is known to decrease expression and function of the endocannabinoid CB1 receptor (Kruse et al. 2019; Rubino et al. 2015; Silva et al. 2016; Stringfield and Torregrossa 2021b; Zamberletti et al. 2012), which is critical for reward-motivated behavior (Cha et al. 2007; Friemel et al. 2014; Hernandez and Cheer 2012; Maccioni et al. 2008; Marusich and Wiley 2012; Rasmussen and Huskinson 2008; Solinas and Goldberg 2005; Ward and Dykstra 2005). We therefore hypothesized that THC exposure, particularly during adolescence, would alter the CB1 receptor dependence of reward-motivated behavior.

Material and methods

All procedures were approved by the UC Irvine Institutional Animal Care and Use Committee (IACUC) and were in carried out in accordance with the National Research Council Guide for the Care and Use of Laboratory Animals.

Animals

Male Long-Evans rats (N = 80) were obtained from Charles River. For adolescent exposure cohorts, rats were weaned at postnatal day (PD) 21 and arrived at our facility at PD 22. Adult exposure cohorts arrived aged approximately 12 weeks. Adult rats were pair-housed throughout the study, whereas adolescent rats were initially housed in groups of four before being pair-housed 1 week prior to behavioral testing (see below for detailed experimental designs). Rats were housed in transparent plastic cages in a temperature- and humidity-controlled vivarium. The rats were tested during the light phase of a standard 12:12 h light:dark schedule, and had ad libitum access to food and water in their home cages throughout the experiment, except when food restricted for specific procedures as indicated below.

Apparatus

Behavioral procedures were conducted in identical operant chambers (ENV-007, Med Associates, St. Albans, VT, USA), each housed in a sound- and light-attenuated cubicle. A food delivery port was located at the center of one end-wall of the chamber, 2.5 cm above the stainless-steel grid floor. Separate cups within the food port were used to deliver sweetened condensed milk (SCM) solution via a syringe pump located outside of the cubicle or 45-mg grain pellets (BioServ) via an automated pellet dispenser. A photobeam detector positioned across the food-port entrance was used to monitor head entries. SCM licking responses were continuously recorded during consumption test sessions using a contact lickometer device (ENV-250B, Med Associates, St. Albans, VT, USA). Locomotor activity was monitored with four photobeams that were positioned in a horizontal plane ~ 2 cm above the grid floor. Each chamber was also equipped with two retractable levers positioned to the left and right of the food port. A houselight (3 W, 24 V) at the top of the opposite end-wall provided general illumination and a fan mounted on the cubicle provided ventilation and background noise. Experimental events were controlled and recorded with a 10-ms resolution using MED-PC IV software.

Drug preparation and treatment

THC was provided by the NIDA Drug Supply Program and was prepared daily by evaporating vehicle under N₂ and dissolving to dose in 5% Tween 80 in saline (1 ml/kg) prior to intraperitoneal injections (Burston et al. 2010; Ruiz et al. 2021; Torrens et al. 2020). Rats were administered a series of 14 once-daily i.p. injections of THC or vehicle beginning at PD 30 for adolescent exposure cohorts (THC n = 20; Veh n = 20) or at 13 weeks postnatal for adult exposure cohorts (THC n = 20; Veh n = 20). Rimonabant (ApexBio Technology) was prepared fresh each day, dissolved in Tween 80/PEG-400/sterile 0.9% saline (1:1:18, vol/vol/vol) and sonicated for 10 min at 30 °C. Vehicle and rimonabant suspension were injected at a volume of 1 ml/kg.

Experiment 1

Overview

Rats (N = 40) were pretreated with THC or vehicle as adolescents or adults, using a fully factorial design (n’s = 10/group). This experiment was run in two replications with fully balanced groups. Behavioral testing began after a washout period of 63–67 days. Rats were food restricted for 3 days before and throughout testing by providing each animal with 10–14 g of home chow at the end of each day to maintain them at ~ 85% of their estimated free-feeding bodyweight. We then investigated the effects of THC pre-exposure on the acquisition and control of instrumental reward-seeking behavior. We specifically probed rats’ ability to make flexible choices between actions based on changes in reward value and action-outcome contingency, which are hallmarks of goal-directed control (Balleine and Dickinson 1998). A schematic overview of experiment 1 is represented in Fig. 1A.

Fig. 1Schematic representation of the timelines for experiments 1 (A) and 2 (B). Deval. test, devaluation test; PR, progressive ratio; trt., treatment

Instrumental action-outcome training

Rats initially received 2 days of magazine training, during which 20 grain pellets and 20 deliveries of 120 µl of 50% SCM were delivered on a random time (RT) 30-s schedule with the levers retracted. Rats were then given 10 days of instrumental training on two distinct action-outcome contingencies (i.e., R1 → O1 and R2 → O2). The left and right lever-press actions were trained in separate sessions each day. Lever-outcome arrangements were counterbalanced with drug treatment conditions, such that, for half of the rats in each group, pressing the left lever produced SCM solution and pressing the right lever produced grain pellets, whereas the other half received the opposite arrangement. Only the active lever (left or right) was extended during individual training sessions, which terminated after 30 min elapsed or 20 rewards were earned. Rats were placed in their home cage for at least 2 h between the two daily training sessions. The schedule used to reinforce lever pressing began with 2 days of fixed ratio (FR)-1 training, but then shifted through a series of increasingly more effortful random ratio (RR) schedules, with 2-day intervals of RR-5, RR-10, and RR-20 training, such that an average of 20 presses were needed to earn each reward during the last phase of instrumental training. Previous studies have shown that rats trained with similar protocols involving multiple action-outcome contingencies tend to prevent habit formation even after overtraining (Colwill and Rescorla 1985; Colwill and Triola 2002; Halbout et al. 2016; Kosaki and Dickinson 2010).

Reward devaluation

We used a specific satiety procedure to assess the effects of post-training reward devaluation on rats’ choice between the two instrumental reward-seeking actions, as in our previous publications (Halbout et al. 2016, 2019; Kosheleff et al. 2018). On test days, rats were given 60 min of unrestricted access to 50% SCM or grain pellets (counterbalanced with pretreatment groups) in their home cages. Rats were then placed in the behavioral chambers for a 15-min test session, during which they had continuous access to both levers. Each test began with a 5-min extinction phase, such that lever presses were recorded but were not reinforced, which was done to probe action selection in the absence of explicit response-contingent feedback, thereby requiring retrieval of previously encoded action-outcome associations (Balleine and Dickinson 1998). This was immediately followed by a 15-min rewarded phase, during which each action was reinforced with its respective outcome. An FR-1 schedule was in place for the first 5 reward deliveries before shifting to a RR-20 schedule for the remainder of the session. The rewarded phase was included as a tool to confirm the efficacy of the specific satiety procedure and to determine rats’ ability to select actions when provided with explicit feedback about the consequences of their actions, which can further promote goal-directed control (Ostlund and Balleine 2008). After the first test, rats were given a session of retraining with each lever using a schedule of reinforcement that shifted within-session with reward delivery, moving from FR-1 (first 3 rewards) to RR-5 (next 5 rewards) to RR-10 (1 reward), before reaching the RR-20 schedule that would remain in place for the remainder of the session. Retraining sessions lasted for 30 min or until 20 rewards were earned. On the following day, rats were given a second reward devaluation test after being satiated on the alternative food outcome.

Action-outcome reversal training and reward devaluation

Following the first round of devaluation testing, rats were given 5 days of instrumental retraining using a RR-20 reinforcement schedule. These sessions used the same parameters as initial instrumental training sessions (see above), except that the original action-outcome contingencies were reversed (i.e., R1 → O2 and R2 → O1), such that the lever that had once produce SCM now produced grain pellets, and vice versa. Rats were then administered a second round of two reward devaluation tests (one with SCM devalued and one with pellets devalued; counterbalanced), as described above, with a session of retraining in between tests using the reversed contingencies. This post-reversal test assays rats’ capacity to use recency to disambiguate conflicting action-outcome associations for flexible, goal-directed decision making (Bradfield and Balleine 2017; Panayi and Killcross 2018; Parkes et al. 2018).

Contingency degradation training and testing

Rats were then retrained on the original action-outcome contingencies (i.e., R1 → O1 and R2 → O2) on an RR-20 schedule for 3 days, as described above. Next, they were given 10 days of instrumental contingency degradation training (Balleine and Dickinson 1998; Corbit et al. 2002; Halbout et al. 2016), which was used to selectively weaken the predictive relationship for one of the two action-outcome contingencies while continuing to reinforce both actions with their original outcomes on a modified RR-20 schedule. Specifically, sessions were divided into a series of 1-s periods, and the first press performed in each period had a 1-in-20 chance of producing reward [p(outcome/response) = 0.05]. As before, the two actions were trained in separate daily sessions, though these sessions were now limited to 20 min without a cap on the number of rewards that could be earned. Importantly, one of the two outcomes (SCM or grain pellets) was also delivered in a noncontingent manner. Specifically, the noncontingent outcome had a 1-in-20 chance of being delivered at the end of any 1-s period without a lever-press response [p(outcome/no response) = 0.05]. The identity of the noncontingent outcome was fixed for individual subjects and was counterbalanced across groups. This outcome was noncontingently delivered in all contingency degradation training sessions, regardless of which lever was available, such that, for degraded sessions, the noncontingent outcome was the same as the response-contingent outcome [e.g., R1 → O1 & No R1 → O1], whereas for nondegraded sessions, the noncontingent outcome was different from the response-contingent outcome [e.g., R2 → O2 & No R2 → O1]. Thus, one action (R1) lost its predictive value because its outcome was just as likely to occur after that action as in its absence, whereas the alternative action remained a unique and reliable predictor of its outcome. Five-min extinction tests were conducted after the 6th and 10th day of contingency degradation training to assess how this procedure altered rats’ choice between actions. At test, both levers were continuously available in the absence of either response-contingent or noncontingent reward delivery.

Experiment 2

Overview

A separate set of rats (N = 40) were pretreated with THC or vehicle as adolescents or adults using a fully factorial design (n’s = 10/group). This experiment was run in two replications with fully balanced groups. Behavioral testing began after a washout period of 23–28 days. Thereafter, we assessed the effects of THC pre-exposure on the hedonic component of feeding during sessions of free access to varying concentrations of SCM solution. We then assessed their motivation, or willingness to exert effort, for SCM using an operant progressive ratio task. After establishing baseline performance, we conducted a dose–response analysis of the response-suppressive effects of rimonabant (CB1 receptor inverse agonist) to assess alterations in CB1 receptor-dependent motivational function. Behavioral testing in this experiment was conducted without food or water restriction except as described below. A schematic overview of experiment 2 is represented in Fig. 1B.

Hedonic feeding

Rats were handled for 3 days prior to testing. During the last 2 days of handling, rats were also given 2 h of free access to a bottle containing 50% SCM to familiarize them with this solution. They were then given 4 daily 30-min sessions to provide them with experience consuming 50% SCM in the behavior chambers. At the beginning of each session, the food cup was filled with 30 µl of SCM over a 0.5-s interval via syringe-pump activation. Cups were refilled whenever rats drank the solution. Specifically, any lick response detected when the syringe pump was inactive resulted in the immediate injection of a new 15 µl volume of SCM, delivered over 0.25 s. Licks detected when the syringe pump was already active were recorded but did not influence the ongoing SCM delivery. This contingency ensured that rats had continuous access to SCM at a maximal delivery rate of 60 µl/s while preventing the cup from being overfilled.

To assess the influence of reward palatability on feeding behavior, rats were given a series of 8 separate 90-min sessions of access to varying concentrations of SCM (5, 10, 25, and 50%). Test order was pseudorandom (Latin square) and counterbalanced. Our primary measure of hedonic feeding was bodyweight-normalized SCM intake (ml/kg) during the first 3 min of active licking behavior (beginning after the first contact with SCM), as in our previous publications (Marshall et al. 2017). This and related measures selectively track the influence of taste palatability on fluid intake while avoiding the inhibitory effects of post-ingestive satiety (Davis and Perez 1993; Davis and Smith 1988). Locomotor behavior (breaks/min) during tests sessions was also analyzed.

Progressive ratio

After assessing hedonic feeding behavior, rats were given instrumental training to lever press for 50% SCM reward (120 ul). Each session ended after 30 min or 20 rewards were earned. Rats were reinforced on a FR-1 schedule during the first 2 sessions and an FR-3 schedule during the next 2 sessions. To facilitate acquisition of the lever-press response, rats were mildly food restricted during these initial FR training sessions. Home chow was removed from their cages the night before the first session, and rats were given 2 h of access to chow per day after each training session. Unrestricted access to chow in the home cage was resumed after the last FR-3 session.

Rats were then trained on a progressive ratio (PR)-3 schedule of reinforcement, with a response requirement that began at 1 press and progressed in 3-press increments for each reward earned in that session (i.e., 1, 4, 7). Rats received 6 initial days of PR-3 training sessions, each lasting 90 min with no limit on the number of rewards that could be earned. The concentration of SCM was set at 50% for all but the 5^th session, when it was shifted to 5% to assess the effect of reward palatability on task performance.

Effects of rimonabant on progressive ratio performance

We then assessed the effects of disrupting CB1 receptor activity on PR-3 task performance, using the same testing procedures described above, with a 50% SCM reward. Thirty-min before each test session, rats were pretreated with varying doses of rimonabant (0, 0.3, 1, and 3 mg/kg, i.p.) in a Latin square design so that the order of each dose treatment was counterbalanced across rats. Each test was followed by at least 1 day off to allow for drug washout and was preceded by 1 day of drug-free retraining on the PR-3 task.

Data analysis

Data were analyzed with univariate or repeated measures ANOVAs in SPSS v. 28. Significance was set at p < 0.05. Significant interactions were followed by an analysis of lower-order interactions or simple effects, as appropriate, to identify contributing factors. Bodyweights on the first and last day of drug exposure and at the beginning of behavioral testing (following drug washout) were analyzed using a two-way ANOVA with drug (THC vs. vehicle exposure) and age (adolescent vs. adult) as factors. Instrumental response rates (presses per minute) were analyzed using mixed ANOVAs which included drug and age as factors in addition to other within-subjects factors as appropriate (see Electronic Supplementary Materials for full ANOVA results tables). Initial action-outcome data were averaged across levers and sessions within each phase of reinforcement before they were analyzed with a drug × age × schedule ANOVA. Subsequent retraining data were analyzed with drug × age × session ANOVAs. Reward devaluation test data were averaged across test pairs (one with each reward devalued) and analyzed separately for each test phase (extinction vs. reinforced) using drug × age × devaluation (devalued vs. nondevalued action) ANOVAs. Instrumental contingency degradation data were normalized to baseline response rates (average of last 3 days of retraining) and were analyzed using a drug × age × degradation (degraded vs. nondegraded action) × session (1–12) ANOVA. Equipment malfunction during contingency degradation training led to a modest loss of data (20 of 800 total data points, or 2.5%), which was dispersed across groups. Missing values were interpolated for data analysis by taking the average response rate in surrounding sessions. Data from the first and second degradation test were analyzed separately using drug × age × degradation ANOVAs. For hedonic feeding tests, we analyzed the temporal pattern of SCM intake (bodyweight normalized) using a drug × age × time (1–30 min) ANOVA. Early (first 3 min) and total intake were also analyzed using a drug × age × concentration (5%, 10%, 25%, 50%) ANOVA, as was total locomotor activity. The number of rewards earned served as our main measure of progressive ratio performance. The effect of SCM concentration on progressive ratio performance was analyzed using a drug × age × concentration (5% vs. 50%) ANOVA. The effect of rimonabant pretreatment on progressive ratio performance was analyzed using a drug × age × dose (0, 0.3, 1, 3 mg/kg) ANOVA, which was followed by an orthogonal polynomial trend analysis to characterize linear and nonlinear dose–response functions (Randall et al. 2011; Wickens and Keppel 2004).

Results

Experiment 1

Bodyweight

Adult exposure groups weighed significantly more than adolescent exposure groups throughout the experiment (see Table 1 for group means and SEM; see Table S1 for full ANOVA results), including during the first (age effect: p < 0.001) and last day of drug treatment (age effect: p < 0.001), and when rats began behavioral testing (age effect: p < 0.001). Bodyweights were balanced across drug groups on the first day of treatment. THC exposure temporarily reduced bodyweight in both age groups, an effect that was observed on the last day of drug treatment (drug effect: p < 0.001) but had dissipated by the time rats began behavioral testing (drug effect: p = 0.18).

Table 1Bodyweights (grams; mean ± SEM) for groups in experiments 1 and 2 on the first and last day of drug treatment and on the day prior to behavioral testing (see Table S1 for ANOVA results)

Group		First injection	Last injection	Prior to testing
Experiment 1	Adolescent-THC	114.2 ± 2.2	188.7 ± 3.4	401.1 ± 12.1
	Adolescent-vehicle	119.3 ± 3.8	216.7 ± 6.4	441.8 ± 20.1
	Adult-THC	368.6 ± 6.1	384.1 ± 6.8	481.2 ± 16.4
	Adult-vehicle	372.0 ± 4.9	409.2 ± 6.4	493.4 ± 14.3
Experiment 2	Adolescent-THC	130.8 ± 6.1	189.1 ± 4.5	427.8 ± 9.4
	Adolescent-vehicle	135.0 ± 8.5	204.6 ± 3.1	428.2 ± 10.7
	Adult-THC	400.7 ± 6.1	403.9 ± 7.2	500.2 ± 13.9
	Adult-vehicle	399.2 ± 10.3	425.8 ± 12.6	504.8 ± 13.7

Initial action-outcome training

Rats were food deprived and trained to perform two lever-press actions for distinct food outcomes (Fig. 2A), which were delivered according to an RR schedule that increased over days, such that task performance became progressively more effortful. As can be seen in Fig. 2B (see Table S2 for full ANOVA results), rats adjust to the increase in effort by increasing their rate of lever pressing (schedule effect: p < 0.001). Response rates were significantly elevated for THC exposed rats (drug effect: p = 0.03), regardless of exposure age (drug × age interaction: p = 0.40). No other effects or interactions reached significance (p’s ≥ 0.14).

Fig. 2Acquisition and goal-directed control of instrumental reward-seeking behavior. A Instrumental response-outcome contingencies used during initial training. B Response rates during initial training plotted as an average for each reinforcement schedule. C Response rates during the extinction (left) and reinforced (right) phases of the initial round of reward devaluation testing, plotted separately for the actions associated with the devalued (Dev) and nondevalued (Non) outcomes, as indicated. D Instrumental contingencies used during reversal training. E Response rates during reversal training sessions. F Response rates during the second round (post-reversal) of reward devaluation testing, as above. Data are shown as mean ± SEM for groups previously exposed to THC or vehicle (Veh) as adolescents or adults, as indicated. FR, fixed ratio; RR, random ratio

Reward devaluation test

Rats then underwent reward devaluation testing to determine whether THC exposure altered their ability to use action-outcome associations for goal-directed decision making (see Table S3 for full ANOVA results). As shown in Fig. 2C (left panel), rats selectively suppress their performance of whichever action earned the devalued reward during the extinction phase of the test (devaluation effect: p < 0.001), demonstrating their capacity for flexible goal-directed action selection. No effects of THC exposure (p = 0.52) or age (p = 0.39) were detected, nor did these factors significantly interact (p’s ≥ 0.24). Sensitivity to reward devaluation was also apparent during the reinforced test phase (Fig. 2C, right panel; devaluation effect: p < 0.001), with no other significant effects or interactions (p’s ≥ 0.16).

Action-outcome reversal training and reward devaluation

We next assessed the effects of THC exposure on rats’ ability to remap action-outcome associations during reversal training (Fig. 2D) and use these updated associations to select actions based on expected reward value. Press rates (Fig. 2E; see Table S4 for full ANOVA results) increased over reversal training sessions (day effect: p < 0.001) and were marginally elevated in THC pretreated rats (drug effect: p = 0.10). No other effects were apparent (p’s ≥ 0.29).

As shown in Fig. 2F, rats use recent action-outcome mappings to select actions during the reward devaluation test (see Table S5 for full ANOVA results). For the extinction phase, there was a significant effect of devaluation (p = 0.005) and no effect of age (p = 0.46) or THC exposure (p = 0.52), nor were there any significant interactions involving these factors (p’s ≥ 0.17). Press rates during the reinforced test phase were also sensitive to reward devaluation (p < 0.001), with no other effects or interactions reaching significance (p’s ≥ 0.23).

Contingency degradation training and testing

We then assessed the effects of THC on rats’ sensitivity to action-outcome contingency degradation. Rats were first retrained with the original action-outcome contingencies to reestablish these associations. Press rates (Fig. 3A; see Table S6 for full ANOVA results) tended to increase over days (p < 0.001). THC exposed rats continued to exhibit significantly higher response rates (drug effect: p = 0.04) regardless of age of exposure (drug × age interaction: p = 0.99). Apart from a marginally significant effect of age (p = 0.09), no other effects or interactions were significant (p’s ≥ 0.13).

Fig. 3Instrumental retraining and instrumental contingency degradation learning. A Response rates during retraining sessions after reward devaluation testing. B Instrumental response-outcome contingencies used during instrumental contingency degradation training, indicating that one of the two outcomes was delivered in both a response-contingent and noncontingent manner. C Baseline-normalized response rates during instrumental contingency degradation training sessions, plotted separately for the actions associated with the degraded (Deg) and nondegraded (Non) contingencies, as indicated. D Baseline-normalized response rates during the early (left) and late (right) contingency degradation test sessions, plotted separately for each action as above. Data are shown as mean ± SEM for groups previously exposed to THC or vehicle (Veh) as adolescents or adults, as indicated

During subsequent contingency degradation sessions, one of the two outcomes was delivered in a response-independent manner, such that the corresponding action was no longer a reliable predictor of reward delivery (Fig. 3B). Press rates were normalized to baseline levels during the pre-training phase to adjust for individual differences. As indicated in Fig. 3C (see Table S7 for full ANOVA results), all groups reduce their overall rate of responding over contingency training sessions (day effect: p = < 0.001), but also selectively reduced their performance of the nonpredictive action (degradation effect: p < 0.001). Apart from a marginal day × degradation interaction (p = 0.056) and drug × age interaction (p = 0.093), no other effects or interactions were detected (p’s ≥ 0.24).

Two extinction tests were conducted to probe the effects of contingency training on choice behavior in the absence of reward delivery (see Table S8 for full ANOVA results). During the first test (Fig. 3D, left panel), which was conducted midway through training, there was a general preference for the predictive (i.e., nondegraded) action (degradation effect: p = 0.02), with no effects or interactions involving drug treatment (p’s ≥ 0.21). During the final test (Fig. 3D, right panel), while there was an overall preference for the predictive action (degradation effect: p < 0.001), the strength of this effect was affected by THC exposure in an age-dependent manner (degradation × age × drug interaction: p = 0.04; all other effects and interactions: p’s ≥ 0.75). This appeared to be driven by a facilitation of contingency learning in the adult-THC group relative to their age-matched control group. Specifically, when data from the vehicle groups were analyzed separately, we found a significant age × degradation interaction (F_1,18 = 4.50, p < 0.05, η_p² = 0.20). While the adolescent-vehicle group displayed a strong preference for the predictive action (simple effect of degradation for adolescent-vehicle rats: F_1,9 = 40.20, p < 0.001, η_p² = 0.82), the adult-vehicle group had yet to develop such a preference by the final test (simple effect of degradation for adult-vehicle rats: F_1,9 = 2.99, p = 0.12, η_p² = 0.25), suggesting a delay in contingency learning. In contrast, THC-exposed rats showed a significant preference for the predictive action (simple effect of degradation for all THC rats: F_1,17 = 13.88, p = 0.002, η_p² = 0.45) that did not interact with age (age × degradation interaction for all THC rats: F_1,17 = 1.14, p = 0.30, η_p² = 0.063). Thus, the adult-THC developed a strong preference for the predictive action (simple effect of degradation for adult-THC rats: F_1,8 = 11.58, p = 0.009, η_p² = 0.59) under conditions that did not support such an effect in the age-matched vehicle control group, suggesting an augmentation of contingency learning.

Experiment 2

Bodyweight

Adult exposure groups weighed significantly more than adolescent exposure groups throughout the experiment (see Table 1 for group means and SEM; see Table S9 for full ANOVA results), including on the first (age effect: p < 0.001) and last day of drug treatment (age effect: p < 0.001), as well as when rats began behavioral testing (age effect: p < 0.001). Drug groups did not differ in bodyweight on the first day of treatment. THC once again temporarily reduced bodyweight in both age groups by the last day of treatment (drug effect: p = 0.02), with no such effect apparent by the beginning behavioral testing (drug effect: p = 0.84).

Hedonic feeding

We first assessed the long-term effects of THC pre-exposure on consumption of a palatable SCM solution (see Table S10 for full ANOVA results). Figure 4A shows the time course of SCM licking behavior (averaged across test sessions), which exhibited a typical within-session satiety profile, with reward intake peaking early in the session before entering a phase of steady decline (time effect: p < 0.001). Licking behavior was not affected by THC exposure (p’s ≥ 0.38 for drug effect and drug-related interactions). While age groups showed similar levels of total (bodyweight-normalized) intake, the time course of consumption did significantly interact with age (time × age interaction: p < 0.001), with older rats showing a more rapid peak and sharper decline during the early phase of intake.

To selectively assay hedonically controlled feeding and control for variability in the initiation of SCM consumption, we calculated intake during the first 3 min of active licking (i.e., after initial contact and before satiety induction; Fig. 4B). As expected, early intake increased with SCM concentration (concentration effect: p < 0.001), reflecting the influence of palatability. Importantly, THC pre-exposure did not alter this measure of hedonic feeding in either age group (p’s ≥ 0.49 for drug effects and interactions), though, as noted above, the adult exposure groups displayed generally higher levels of early intake (age effect: p = 0.01).

The total intake (Fig. 4C) during consumption sessions was negatively related to SCM concentration (concentration effect: p < 0.001), consistent with more concentrated (and calorie-dense) solutions producing greater satiety. This measure was not significantly altered by THC exposure in either age group, nor were there differences between age groups (p’s ≥ 0.49). Thus, we found no evidence of a long-term impact of THC pre-exposure on hedonic feeding behavior or its modulation by satiety.

However, THC exposure did alter locomotor activity at test, as shown in Fig. 4D. As with total intake, locomotor activity decreased as a function of SCM concentration (concentration effect: p < 0.001), suggesting a relationship to feeding and satiety. There was also a nonspecific effect of age on locomotor behavior (age effect: p < 0.001), with adolescent exposure groups showing higher levels of activity. Moreover, there was an age-specific effect of THC exposure on locomotor activity (drug × age interaction: p = 0.01). Specifically, rats exposed to THC as adults showed higher levels of locomotor activity than the adult-vehicle group (simple effect of drug for adult rats: F_1,17 = 12.90, p = 0.002, η_p² = 0.43), whereas no such effect was observed following adolescent THC exposure (simple effect of drug for adolescent rats: F_1,18 = 1.16, p = 0.30, η_p² = 0.061).

Progressive ratio

We then assessed the effect of THC pre-exposure on rats’ motivation to work for SCM reward on an instrumental PR task. Once stable PR performance was established, rats were given separate PR tests with 5% or 50% SCM reward (Fig. 5A; see Table S11 for full ANOVA results). As expected, PR performance was strongly influenced by SCM concentration, with rats earning significantly more 50% than 5% reward (concentration effect: p < 0.001). Although PR performance appeared to be elevated in THC pretreated rats, particularly in the adult exposure condition, our analysis did not detect a significant effect of drug exposure (p = 0.15) or age (p = 0.70), nor were there any significant interactions involving these factors (p’s ≥ 0.18). Given the trends in the data, Bonferroni-corrected post-hoc tests were conducted to assess the effect of THC for each age group (significance set at 0.025 = 0.05/2). The simple effect of drug was marginal in the adult-exposure condition (p = 0.04, η_p² = 0.22) and well above the threshold for significance in the adolescent-exposure condition (p = 0.95, η_p² = 0.000).

Effects of rimonabant on progressive ratio performance

We administered an additional series of tests to further probe the motivational effects of THC pre-exposure and its neurochemical basis. THC exposure is known to cause long-term changes in the expression and function of the CB1 receptor (Kruse et al. 2019; Rubino et al. 2015; Stringfield and Torregrossa 2021b; Zamberletti et al. 2012), which plays an important role in regulating reward-motivated PR performance (Friemel et al. 2014; Hernandez and Cheer 2012; Maccioni et al. 2008; Marusich and Wiley 2012; Rasmussen and Huskinson 2008; Solinas and Goldberg 2005; Ward and Dykstra 2005). We hypothesized that THC exposure might therefore alter the CB1 receptor dependence of motivated behavior. To test this possibility, rats were pretreated with varying doses of rimonabant (0, 0.3, 1, 3 mg/kg) prior to PR testing. An orthogonal polynomial trend analysis was conducted to characterize linear and nonlinear dose–response functions (Randall et al. 2011; Wickens and Keppel 2004).

Rimonabant resulted in a dose-dependent reduction in the number of rewards earned on the PR task (Fig. 5B; see Table S12 for full ANOVA results), as indicated by a significant linear trend (p < 0.001) and a marginally significant quadratic trend (p = 0.06) of dose. There were also marginally significant linear (p = 0.08) and quadratic dose × drug × age interactions (p = 0.07), suggesting that the groups may have differed in their sensitivity to rimonabant. No other effects or interactions were detected (p’s ≥ 0.24), apart from a marginally significant main effect of drug exposure (p = 0.06), which was related to a THC-induced elevation in PR performance in the adult-exposure condition (simple effect of drug exposure for adult rats: F_1,17 = 5.40, p = 0.03, η_p² = 0.24) but not in the adolescent-exposure condition (simple effect of drug exposure for adolescent rats F_1,18 = 0.29, p = 0.60, η_p² = 0.016). When trend analyses were conducted separately for each group, both adult- and adolescent-vehicle groups exhibited a linear trend of rimonabant dose (adult: F_1,8 = 8.30, p = 0.02, η_p² = 0.51; adolescent: F_1,9 = 11.06, p = 0.009, η_p² = 0.55), indicating a steady decline in PR performance with increasing drug doses. In contrast, a significant quadratic trend (F_1,8 = 9.42, p = 0.01, η_p² = 0.51) was detected for the adult-THC group, suggesting greater sensitivity to rimonabant, characterized by a sharper decline in PR performance. The adolescent-THC group also differed from controls, in this case showing diminished sensitivity to rimonabant (linear trend: F_1,9 = 2.32, p = 0.16, η_p² = 0.21; quadratic trend: F_1,19 = 0.17, p = 0.67, η_p² = 0.019).

Discussion

Previous research indicates that chronic exposure to high doses of THC during adolescence can blunt reward processing (Realini et al. 2011; Rubino et al. 2008; Scherma et al. 2016). Less is known about how reward-related behavior is impacted by more moderate THC exposure. The current study investigated this issue using a 2-week regimen of once-daily 5 mg/kg THC injections, which has been shown to support human-relevant levels of drug exposure (Ruiz et al. 2021; Torrens et al. 2020). We found that neither adolescent nor adult THC exposure caused long-term effects on hedonic feeding behavior or its regulation by satiety. Interestingly, both treatments tended to increase, rather than decrease, the vigor of instrumental performance for palatable food reward. This latter finding is consistent with recent reports that cue-motivated behavior is elevated in adulthood following adolescent exposure to relatively low doses of THC (Kruse et al. 2019; Orihuel et al. 2021). Such findings suggest that heavy and more moderate THC dosing regimens may have distinct long-term effects on reward processing and motivated behavior.

Our findings are generally in line with the view that drug-induced adaptations in the brain’s motivational hardware, particularly within the mesolimbic dopamine system, can lead to a long-term uptick in the desire to pursue rewards (i.e., “wanting”) (Berridge and Robinson 2016; Robinson and Berridge 1993). This increased motivation is thought to drive compulsive drug-seeking behavior but may also spillover to increase the pursuit of other nondrug rewards. For instance, previous studies have shown that rats with a history of cocaine, amphetamine, or morphine exposure exhibit an increased willingness to exert effort for palatable food reward (Forouzan et al. 2021; Mendez et al. 2009; Nordquist et al. 2007; Rouibi and Contarino 2012), as was observed in the current study after repeated THC exposure. This heightened motivation is thought to be mediated by increased mesolimbic dopamine signaling (Berridge and Robinson 2016; Robinson and Berridge 1993), which is consistent with previous reports that repeated THC exposure causes long-lasting hyperactivity in mesolimbic dopamine neurons (De Felice and Laviolette 2021; Renard et al. 2017) and sensitizes dopamine release in the nucleus accumbens core (Cadoni et al. 2008).

Nonspecific motivational changes arising from drug exposure may reflect an aberrant incentive process that can increase vulnerability to substance use disorder or other pathological forms of reward seeking. While there have been numerous reports of cannabinoid pre-exposure increasing voluntary opioid intake (Biscaia et al. 2008; Ellgren et al. 2007; Norwood et al. 2003; Solinas et al. 2004; Spano et al. 2007; Tomasiewicz et al. 2012; Vela et al. 1998); (Ferland et al. 2022), this effect does not appear to increase willingness to exert effort for opioid reward on a progressive ratio schedule (Biscaia et al. 2008; González et al. 2004; Solinas et al. 2004). However, such studies have explored a limited range of drug pre-exposure regimens mostly involving potent synthetic cannabinoids or high doses of THC (but see Ferland et al. 2022; González et al. 2004), which should encourage further research on this topic.

Our findings suggest that the long-term effects of THC on motivation may be at least partly influenced by exposure age. In experiment 2, progressive ratio performance tended to be elevated following adult—but not adolescent—THC exposure, relative to age-matched controls. These treatments also had opposing effects on the CB1 receptor dependence of progressive ratio performance, as discussed below. Furthermore, locomotor activity during consumption test sessions was elevated in the adult-THC group but not in the adolescent-THC group, even though SCM intake was not itself significantly altered by THC exposure. Locomotor activity during these sessions varied with SCM concentration and likely relates to generalized reward-seeking behavior. Altogether, these findings suggest that adult-THC exposure may be particularly effective at inducing persistent elevations in motivational arousal. These putative age-dependent motivational effects of THC deserve further investigation and may indicate that the adolescent brain is resilient to this long-term effect of THC exposure. This would be in keeping with recent findings that acutely administered THC is more rapidly metabolized and results in lower drug concentrations in the brain and attenuated locomotor effects in adolescent versus adult mice (Torrens et al. 2020). However, numerous previous studies indicate that adolescent animals are more—not less—sensitive to the long-term term cognitive and behavioral effects of cannabinoid drugs (Gleason et al. 2012; O'Shea et al. 2004; Quinn et al. 2008; Renard et al. 2013; Schneider and Koch 2003), which again highlights the need for further research.

THC exposure also led to more vigorous instrumental performance for food reward in experiment 1, but in this case, the effect occurred after both adolescent and adulthood THC exposure. It is possible that the behavioral testing conditions used in experiment 2 were more effective in exposing age-related variation in this persistent motivational effect of THC exposure. In experiment 2, rats were tested on a progressive ratio schedule without food restriction in order to probe motivation related to the hedonic-emotional properties of the food reward and not its caloric-energetic properties. In contrast, rats responded for food reward on a random ratio schedule under chronic food restriction in experiment 1 in order to support the planned testing procedures (e.g., reward devaluation through specific satiety). The use of hunger to inflate reward value in experiment 1 may have provided a more sensitive (albeit less selective) test of motivation, thereby unmasking a potentially more subtle motivational enhancement related to adolescent-THC exposure that was not expressed in experiment 2. This is in line with other recent studies showing that adolescent THC exposure enhances cue-motivated behavior under chronic food restriction (Kruse et al. 2019; Orihuel et al. 2021).

The endocannabinoid system is an important modulator of reward-motivated behavior (Sallam and Borgland 2021), an influence that is mediated in part by CB1 receptor-dependent facilitation of mesolimbic dopamine release (Melis et al. 2007; Oleson et al. 2012). Importantly, exogenous cannabinoid exposure triggers long-lasting adaptations in the endocannabinoid system, including in brain regions that encompass mesolimbic dopamine circuitry (Burston et al. 2010; Perdikaris et al. 2018; Rubino et al. 2015; Sim-Selley 2003; Zamberletti et al. 2012). We hypothesized that changes in the motivational effects of THC exposure may reflect underlying changes in the influence of CB1 receptor activity on reward-motivated behavior. Consistent with this possibility, our findings suggest that rats exposed to THC as adults tended to be more sensitive to the response-suppressive effects of rimonabant than age-matched controls. In contrast, rats exposed to THC during adolescence appeared to be less sensitive than controls to rimonabant-induced response suppression. These findings suggest that adult and adolescent THC exposure may exert distinct effects on endocannabinergic mechanisms of motivated behavior. Previous studies have shown that adolescent THC exposure leads to widespread downregulation and desensitization of the CB1 receptor and decreases availability of its endogenous ligands anandamide and 2-arachidonoyl-sn-glycerol (Rubino et al. 2015; Zamberletti et al. 2012). Interestingly, adolescent exposure to a relatively low-dose THC regimen (1–5 mg/kg day) is reported to selectively downregulate CB1 receptors on glutamatergic but not GABAergic synaptic terminals in the ventral tegmental area (Kruse et al. 2019). Such an adaptation would tend to disinhibit mesolimbic dopamine neurons, potentially increasing their responsivity to reinforcing and motivating stimuli. While less is known about the impact of adult THC exposure on the endocannabinoid system, it has been shown to increase CB1 receptor mRNA expression in the striatum (Romero et al. 1997), which may relate to the increased sensitivity to rimonabant observed here after adult THC exposure.

Chronic cannabinoid exposure can cause long-term deficits in cognition and higher-order executive function (Murphy et al. 2017; O'Shea et al. 2004; Quinn et al. 2008; Schneider and Koch 2003). Goal-directed decision making is a hallmark of executive control that is essential for adaptive behavior (Balleine and O'Doherty 2010). The loss of adaptive, goal-directed behavior may contribute to the inflexible, compulsive reward seeking that characterizes substance use disorders (Belin et al. 2013; Everitt and Robbins 2005; Ostlund and Balleine 2008). The effects of cannabinoid exposure on goal-directed behavior are not well understood. Mice given repeated THC exposure as adults have been reported to display insensitivity to reward devaluation under conditions that support flexible, goal-directed behavior in controls (Nazzaro et al. 2012). In other more recent studies, rats with a history of adolescent cannabinoid exposure displayed normal or even enhanced sensitivity to reward devaluation (Ferland et al. 2022; Orihuel et al. 2021). Importantly, these studies were focused on the transition from goal-directed to habitual control and therefore employed simple instrumental testing protocols that promote habit formation. When this approach is used, insensitivity to reward devaluation may reflect an increase in habit formation rather than a deficit in goal-directed decision making. The current study used an alternative approach in which rats were trained on a more complex two-contingency instrumental task that prevents habit formation (Colwill and Rescorla 1985; Colwill and Triola 2002; Halbout et al. 2016; Kosaki and Dickinson 2010), allowing us to more selectively assay goal-directed decision making. With this approach, we found that repeated THC exposure had no lasting effect on rats’ ability to flexibly choose between actions based on expected outcome value. This was true regardless of whether THC was administered during adolescence or adulthood, or whether testing was conducted after initial action-outcome training or after action-outcome reversal learning, which engages distinct cortical networks (Bradfield and Hart 2020; Fresno et al. 2019; Panayi and Killcross 2018; Parkes et al. 2018).

The current study also investigated the effects of THC exposure on instrumental contingency degradation training, which involves learning to withhold a goal-directed action that has lost its predictive value, and thus its utility for obtaining reward. We found that contingency degradation learning was facilitated in rats with a history of adult, but not adolescent, THC exposure. Interestingly, previous studies have found that repeated exposure to cocaine (Halbout et al. 2016) or amphetamine (Phillips and Vugler 2011) similarly enhances instrumental contingency degradation learning, suggesting that this may be a common consequence of repeated drug exposure. Future studies should probe the role of the mesocorticolimbic dopamine system in this phenomenon given that it is both crucially involved in instrumental contingency learning (Naneix et al. 2009) and persistently dysregulated by THC (Higuera-Matas et al. 2015; Perdikaris et al. 2018; Poulia et al. 2021; Renard et al. 2017; Zamberletti et al. 2012) and other abused drugs, including cocaine and amphetamine (Berridge and Robinson 2016; Pierce and Kalivas 1997; Steketee 2003).

It is notable that the enhanced contingency learning displayed by the adult-THC group reflects an improvement relative to the poor performance of the adult-vehicle group, but not relative to the otherwise good performance of the adolescent exposure groups. Unlike these other groups, the adult-vehicle group failed to selectively withhold the nonpredictive (degraded) action during the final test, despite receiving 10 days of contingency training. This delay in learning is not entirely surprising given that contingency degradation training was conducted after a period of reversal training, which may have created some ambiguity in the action-outcome relationships. Even when more conventional procedures are used, rats may require 12 or more days of training for the contingency degradation effect to emerge (Braun and Hauber 2012; Corbit and Balleine 2003; Corbit et al. 2002). In fact, previous reports of enhanced contingency degradation learning in psychostimulant-exposed rats also involved versions of this task that were difficult for control groups to learn (Halbout et al. 2016; Phillips and Vugler 2011). Such conditions may facilitate the detection of augmented contingency degradation learning after drug exposure. This finding may relate to previous reports that chronic low-dose THC exposure can promote neurogenesis (Cao et al. 2014; Jiang et al. 2005; Suliman et al. 2018) and improve cognition and memory in mature and aged, but not young, mice (Bilkei-Gorzo et al. 2017; Sarne et al. 2018). Such findings have raised the possibility that late-life cannabis use may have neuroprotective effects (Weinstein and Sznitman 2020).

An important limitation of the current study is that we investigated the consequences of THC exposure exclusively in male rats. This is notable given previous reports of sex differences in the effects of chronic cannabinoid drug exposure (Calakos et al. 2017; Cooper and Craft 2018; Ginder et al. 2022; Rubino et al. 2015; Stringfield and Torregrossa 2021a). This includes recent studies showing that males and females differ in their sensitivity to the long-term disruptive effects of adolescent cannabinoid exposure on cognition (Mateos et al. 2011; Poulia et al. 2020; Weed et al. 2016), as well as food or drug-motivated behaviors (Biscaia et al. 2008; Higuera-Matas et al. 2015; Nguyen et al. 2020; Orihuel et al. 2021). Given this growing body of work identifying sex as an important factor regulating the long-term behavioral consequences of chronic THC exposure and THC pharmacokinetics (Ruiz et al. 2021), future studies should explore the role of sex in the motivational and cognitive effects observed here in male rats.

In conclusion, the current findings demonstrate that repeated exposure to a moderate dose of THC can cause long-term motivational and cognitive effects in male rats, particularly when that exposure occurs during adulthood. These findings are notable given that the prevalence of cannabis use has sharply increased in recent years for both young (Patrick et al. 2022) and older adults (Han and Palamar 2018). Further research on how chronic THC exposure impacts both the developing and aging brain is therefore warranted.

Supplementary Information

Untitled section

Below is the link to the electronic supplementary material.

Acknowledgements

We thank Johanna Montesinos for assisting with animal pretreatment.

Author contribution

BH, SBO, and SVM contributed to the conception and design of the study and were responsible for writing the manuscript. BH, CH, and LH performed the experiments. VI performed the drug treatment. BH and SBO analyzed the data. All authors approved the submitted version of the manuscript.

Funding

This research was supported by a pilot grant from NIDA P50 award DA044118 and NIH grants MH126285 (SBO), DA046667 (SBO), DA050116 (BH), P50 DA044118 (SVM), and U01DA053826 (SVM).

Data Availability

Data generated and analyzed during the current study will be made freely available from the corresponding authors upon request.

Declarations

Conflict of interest

The authors declare no competing interests.

Footnotes

Footnote Group

Contributor Information

Briac Halbout, Email: halboutb@uci.edu.

Sean B. Ostlund, Email: sostlund@uci.edu

References

Untitled section

References

Balleine BW. The meaning of behavior: discriminating reflex and volition in the brain. Neuron. 2019;104:47–62. doi: 10.1016/j.neuron.2019.09.024.
Balleine BW, Dickinson A. Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology. 1998;37:407–419. doi: 10.1016/S0028-3908(98)00033-1.
Balleine BW, O'Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology. 2010;35:48–69. doi: 10.1038/npp.2009.131.
Bambico FR, Nguyen N-T, Katz N, Gobbi G. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol Dis. 2010;37:641–655. doi: 10.1016/j.nbd.2009.11.020.
Belin D, Belin-Rauscent A, Murray JE, Everitt BJ. Addiction: failure of control over maladaptive incentive habits. Curr Opin Neurobiol. 2013;23:564–572. doi: 10.1016/j.conb.2013.01.025.
Berridge KC, Robinson TE. Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol. 2016;71:670–679. doi: 10.1037/amp0000059.
Bilkei-Gorzo A, Albayram O, Draffehn A, Michel K, Piyanova A, Oppenheimer H, Dvir-Ginzberg M, Rácz I, Ulas T, Imbeault S. A chronic low dose of Δ 9-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat Med. 2017;23:782. doi: 10.1038/nm.4311.
Biscaia M, Fernández B, Higuera-Matas A, Miguéns M, Viveros M-P, García-Lecumberri C, Ambrosio E. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system. Neuropharmacology. 2008;54:863–873. doi: 10.1016/j.neuropharm.2008.01.006.
Bradfield LA, Balleine BW. Thalamic Control of Dorsomedial Striatum Regulates Internal State to Guide Goal-Directed Action Selection. J Neurosci. 2017;37:3721. doi: 10.1523/JNEUROSCI.3860-16.2017.
Bradfield LA, Hart G. Rodent medial and lateral orbitofrontal cortices represent unique components of cognitive maps of task space. Neurosci Biobehav Rev. 2020;108:287–294. doi: 10.1016/j.neubiorev.2019.11.009.
Braun S, Hauber W. Striatal dopamine depletion in rats produces variable effects on contingency detection: Task-related influences. Eur J Neurosci. 2012;35:486–495. doi: 10.1111/j.1460-9568.2011.07969.x.
Burston JJ, Wiley JL, Craig AA, Selley DE, Sim-Selley LJ. Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9-tetrahydrocannabinol exposure. Br J Pharmacol. 2010;161:103–112. doi: 10.1111/j.1476-5381.2010.00870.x.
Cadoni C, Valentini V, Di Chiara G. Behavioral sensitization to Δ9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. J Neurochem. 2008;106:1586–1593. doi: 10.1111/j.1471-4159.2008.05503.x.
Calakos KC, Bhatt S, Foster DW, Cosgrove KP. Mechanisms underlying sex differences in cannabis use. Curr Addict Rep. 2017;4:439–453. doi: 10.1007/s40429-017-0174-7.
Cao C, Li Y, Liu H, Bai G, Mayl J, Lin X, Sutherland K, Nabar N, Cai J. The potential therapeutic effects of THC on Alzheimer's disease. J Alzheimers Dis. 2014;42:973–984. doi: 10.3233/JAD-140093.
Cass DK, Flores-Barrera E, Thomases DR, Vital WF, Caballero A, Tseng KY. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex. Mol Psychiatry. 2014;19:536–543. doi: 10.1038/mp.2014.14.
Cha YM, Jones KH, Kuhn CM, Wilson WA, Swartzwelder HS (2007) Sex differences in the effects of Δ9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behav Pharmacol 18
Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: susceptibility to psychiatric illness. Front Psychiatry. 2013;4:129. doi: 10.3389/fpsyt.2013.00129.
Colwill RM, Rescorla RA. Instrumental responding remains sensitive to reinforcer devaluation after extensive training. J Exp Psychol Anim Behav Process. 1985;11:520. doi: 10.1037/0097-7403.11.4.520.
Colwill RM, Triola SM. Instrumental responding remains under the control of the consequent outcome after extended training. Behav Proc. 2002;57:51–64. doi: 10.1016/S0376-6357(01)00204-2.
Cooper ZD, Craft RM. Sex-dependent effects of cannabis and cannabinoids: a translational perspective. Neuropsychopharmacol. 2018;43:34–51. doi: 10.1038/npp.2017.140.
Copeland J, Swift W, Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. J Subst Abuse Treat. 2001;20:45–52. doi: 10.1016/S0740-5472(00)00148-3.
Corbit LH, Balleine BW. The role of prelimbic cortex in instrumental conditioning. Behav Brain Res. 2003;146:145–157. doi: 10.1016/j.bbr.2003.09.023.
Corbit LH, Ostlund SB, Balleine BW. Sensitivity to instrumental contingency degradation is mediated by the entorhinal cortex and its efferents via the dorsal hippocampus. J Neurosci. 2002;22:10976–10984. doi: 10.1523/JNEUROSCI.22-24-10976.2002.
Corbit LH, Chieng BC, Balleine BW. Effects of repeated cocaine exposure on habit learning and reversal by N-acetylcysteine. Neuropsychopharmacol. 2014;39:1893–1901. doi: 10.1038/npp.2014.37.
Crews F, He J, Hodge C. Adolescent cortical development: A critical period of vulnerability for addiction. Pharmacol Biochem Behav. 2007;86:189–199. doi: 10.1016/j.pbb.2006.12.001.
Davis JD, Perez MC. Food deprivation- and palatability-induced microstructural changes in ingestive behavior. Am J Physiol-Regul, Integr Comp Physiol. 1993;264:R97–R103. doi: 10.1152/ajpregu.1993.264.1.R97.
Davis JD, Smith GP. Analysis of lick rate measure the positive and negative feedback effects of carbohydrates on eating. Appetite. 1988;11:229–238. doi: 10.1016/S0195-6663(88)80005-9.
Ellgren M, Spano SM, Hurd YL. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology. 2007;32:607–615. doi: 10.1038/sj.npp.1301127.
Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005;8:1481–1489. doi: 10.1038/nn1579.
De Felice M, Laviolette SR (2021) Reversing the psychiatric effects of neurodevelopmental cannabinoid exposure: exploring pharmacotherapeutic interventions for symptom improvement. Int J Mol Sci 22
Ferland JN, Ellis RJ, Rompala G, Landry JA, Callens JE, Ly A, Frier MD, Uzamere TO, Hurd YL (2022) Dose mediates the protracted effects of adolescent THC exposure on reward and stress reactivity in males relevant to perturbation of the basolateral amygdala transcriptome. Mol Psychiatry
Ferland J-MN, Hurd YL. Deconstructing the neurobiology of cannabis use disorder. Nat Neurosci. 2020;23:600–610. doi: 10.1038/s41593-020-0611-0.
Forouzan S, Nieto SJ, Kosten TA. Persistence of operant responding for food after prior cocaine exposure in Fischer 344 but not Lewis rats. Am J Addict. 2021;30:358–365. doi: 10.1111/ajad.13152.
Fresno V, Parkes SL, Faugère A, Coutureau E, Wolff M. A thalamocortical circuit for updating action-outcome associations. Elife. 2019;8:e46187. doi: 10.7554/eLife.46187.
Friemel CM, Zimmer A, Schneider M. The CB1 receptor as an important mediator of hedonic reward processing. Neuropsychopharmacology. 2014;39:2387–2396. doi: 10.1038/npp.2014.86.
Ginder DE, Wright HR, McLaughlin RJ. The stoned age: sex differences in the effects of adolescent cannabinoid exposure on prefrontal cortex structure and function in animal models. Int Rev Neurobiol. 2022;161:121–145. doi: 10.1016/bs.irn.2021.07.005.
Gleason KA, Birnbaum SG, Shukla A, Ghose S. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry. 2012;2:e199–e199. doi: 10.1038/tp.2012.122.
González S, Fernández-Ruiz J, Marzo VD, Hernández M, Arévalo C, Nicanor C, Cascio MG, Ambrosio E, Ramos JA. Behavioral and molecular changes elicited by acute administration of SR141716 to Δ9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. Drug Alcohol Depend. 2004;74:159–170. doi: 10.1016/j.drugalcdep.2003.12.011.
Halbout B, Liu AT, Ostlund SB. A closer look at the effects of repeated cocaine exposure on adaptive decision-making under conditions that promote goal-directed control. Front Psychiatry. 2016;7:44. doi: 10.3389/fpsyt.2016.00044.
Halbout B, Marshall AT, Azimi A, Liljeholm M, Mahler SV, Wassum KM, Ostlund SB. Mesolimbic dopamine projections mediate cue-motivated reward seeking but not reward retrieval in rats. Elife. 2019;8:e43551. doi: 10.7554/eLife.43551.
Hammond D, Wadsworth E, Reid JL, Burkhalter R. Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 2019. Drug Alcohol Depend. 2021;219:108505. doi: 10.1016/j.drugalcdep.2020.108505.
Han BH, Palamar JJ. Marijuana use by middle-aged and older adults in the United States, 2015–2016. Drug Alcohol Depend. 2018;191:374–381. doi: 10.1016/j.drugalcdep.2018.07.006.
Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. Jama Psychiat. 2015;72:1235–1242. doi: 10.1001/jamapsychiatry.2015.1858.
Hernandez G, Cheer JF. Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats. J Neurosci. 2012;32:11467–11477. doi: 10.1523/JNEUROSCI.1833-12.2012.
Higuera-Matas A, Ucha M, Ambrosio E. Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes. Neurosci Biobehav Rev. 2015;55:119–146. doi: 10.1016/j.neubiorev.2015.04.020.
Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018;19:470–484. doi: 10.1038/s41583-018-0029-9.
Jacobs-Brichford E, Manson KF, Roitman JD. Effects of chronic cannabinoid exposure during adolescence on reward preference and mPFC activation in adulthood. Physiol Behav. 2019;199:395–404. doi: 10.1016/j.physbeh.2018.12.006.
Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji S-P, Bai G, Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic-and antidepressant-like effects. J Clin Investig. 2005;115:3104–3116. doi: 10.1172/JCI25509.
Kosaki Y, Dickinson A. Choice and contingency in the development of behavioral autonomy during instrumental conditioning. J Exp Psychol Anim Behav Process. 2010;36:334. doi: 10.1037/a0016887.
Kosheleff AR, Araki J, Tsan L, Chen G, Murphy NP, Maidment NT, Ostlund SB. Junk Food Exposure Disrupts Selection of Food-Seeking Actions in Rats. Front Psychiatry. 2018;9:350. doi: 10.3389/fpsyt.2018.00350.
Kruse LC, Cao JK, Viray K, Stella N, Clark JJ. Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood. Neuropsychopharmacology. 2019;44:1406–1414. doi: 10.1038/s41386-019-0387-7.
LeBlanc KH, Maidment NT, Ostlund SB. Repeated cocaine exposure facilitates the expression of incentive motivation and induces habitual control in rats. PLoS ONE. 2013;8:e61355. doi: 10.1371/journal.pone.0061355.
Levine A, Clemenza K, Rynn M, Lieberman J. Evidence for the risks and consequences of adolescent cannabis exposure. J Am Acad Child Adolesc Psychiatry. 2017;56:214–225. doi: 10.1016/j.jaac.2016.12.014.
Lubman DI, Cheetham A, Yucel M. Cannabis and adolescent brain development. Pharmacol Ther. 2015;148:1–16. doi: 10.1016/j.pharmthera.2014.11.009.
Maccioni P, Pes D, Carai MAM, Gessa GL, Colombo G. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Behav Pharmacol. 2008;19:197–209. doi: 10.1097/FBP.0b013e3282fe8888.
Marshall AT, Liu AT, Murphy NP, Maidment NT, Ostlund SB. Sex-specific enhancement of palatability-driven feeding in adolescent rats. PLoS ONE. 2017;12:e0180907. doi: 10.1371/journal.pone.0180907.
Marusich JA, Wiley JL. Rimonabant eliminates responsiveness to workload changes in a time-constrained food-reinforced progressive ratio procedure in rats. Pharmacol Biochem Behav. 2012;101:575. doi: 10.1016/j.pbb.2012.03.004.
Mateos B, Borcel E, Loriga R, Luesu W, Bini V, Llorente R, Castelli MP, Viveros MP. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors. J Psychopharmacol. 2011;25:1676–1690. doi: 10.1177/0269881110370503.
Melis T, Succu S, Sanna F, Boi A, Argiolas A, Melis MR. The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci Lett. 2007;419:231–235. doi: 10.1016/j.neulet.2007.04.012.
Mendez IA, Williams MT, Bhavsar A, Lu AP, Bizon JL, Setlow B. Long-lasting sensitization of reward-directed behavior by amphetamine. Behav Brain Res. 2009;201:74–79. doi: 10.1016/j.bbr.2009.01.034.
Moore BA, Budney AJ. Relapse in outpatient treatment for marijuana dependence. J Subst Abuse Treat. 2003;25:85–89. doi: 10.1016/S0740-5472(03)00083-7.
Murphy M, Mills S, Winstone J, Leishman E, Wager-Miller J, Bradshaw H, Mackie K. Chronic adolescent Δ9-tetrahydrocannabinol treatment of male mice leads to long-term cognitive and behavioral dysfunction, which are prevented by concurrent cannabidiol treatment. Cannabis Cannabinoid Res. 2017;2:235–246. doi: 10.1089/can.2017.0034.
Naneix F, Marchand AR, Scala GD, Pape J-R, Coutureau E. A role for medial prefrontal dopaminergic innervation in instrumental conditioning. J Neurosci. 2009;29:6599. doi: 10.1523/JNEUROSCI.1234-09.2009.
Nazzaro C, Greco B, Cerovic M, Baxter P, Rubino T, Trusel M, Parolaro D, Tkatch T, Benfenati F, Pedarzani P, Tonini R. SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat Neurosci. 2012;15:284–293. doi: 10.1038/nn.3022.
Nelson A, Killcross S. Amphetamine exposure enhances habit formation. J Neurosci. 2006;26:3805–3812. doi: 10.1523/JNEUROSCI.4305-05.2006.
Nelson AJD, Killcross S. Accelerated habit formation following amphetamine exposure is reversed by D1, but enhanced by D2, receptor antagonists. Front Neurosci. 2013;7:76. doi: 10.3389/fnins.2013.00076.
Nguyen JD, Creehan KM, Kerr TM, Taffe MA. Lasting effects of repeated ∆(9) -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats. Br J Pharmacol. 2020;177:188–203. doi: 10.1111/bph.14856.
Nordquist RE, Voorn P, De Mooij-van Malsen JG, Joosten R, Pennartz CMA, Vanderschuren L. Augmented reinforcer value and accelerated habit formation after repeated amphetamine treatment. Eur Neuropsychopharmacol. 2007;17:532–540. doi: 10.1016/j.euroneuro.2006.12.005.
Norwood CS, Cornish JL, Mallet PE, McGregor IS. Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharmacol. 2003;465:105–114. doi: 10.1016/S0014-2999(03)01455-9.
O’Shea M, Singh ME, McGregor IS, Mallet PE. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol. 2004;18:502–508. doi: 10.1177/0269881104047277.
Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron. 2012;73:360–373. doi: 10.1016/j.neuron.2011.11.018.
Orihuel J, Capellan R, Roura-Martinez D, Ucha M, Ambrosio E, Higuera-Matas A (2021) Delta 9-tetrahydrocannabinol during adolescence reprograms the nucleus accumbens transcriptome affecting reward processing, impulsivity, and specific aspects of cocaine addiction-like behavior in a sex-dependent manner. Int J Neuropsychopharmacol
O'Shea M, Singh ME, McGregor IS, Mallet PE. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol. 2004;18:502–508. doi: 10.1177/026988110401800407.
Ostlund SB, Balleine BW. On habits and addiction: an associative analysis of compulsive drug seeking. Drug Discov Today Dis Model. 2008;5:235–245. doi: 10.1016/j.ddmod.2009.07.004.
Panayi MC, Killcross S. Functional heterogeneity within the rodent lateral orbitofrontal cortex dissociates outcome devaluation and reversal learning deficits. Elife. 2018;7:e37357. doi: 10.7554/eLife.37357.
Parkes SL, Ravassard PM, Cerpa J-C, Wolff M, Ferreira G, Coutureau E. Insular and ventrolateral orbitofrontal cortices differentially contribute to goal-directed behavior in rodents. Cereb Cortex. 2018;28:2313–2325. doi: 10.1093/cercor/bhx132.
Patrick ME, Schulenberg JE, Miech RA, Johnston LD, O'Malley PM, Bachman JG. Monitoring the future panel study annual report: national data on substance use among adults ages 19 to 60, 1976–2021. Institute for Social Research; 2022.
Perdikaris P, Tsarouchi M, Fanarioti E, Natsaridis E, Mitsacos A, Giompres P. Long lasting effects of chronic WIN55,212–2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain. Neuropharmacology. 2018;129:1–15. doi: 10.1016/j.neuropharm.2017.11.005.
Phillips GD, Vugler A. Effects of sensitization on the detection of an instrumental contingency. Pharmacol Biochem Behav. 2011;100:48–58. doi: 10.1016/j.pbb.2011.07.009.
Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev. 1997;25:192–216. doi: 10.1016/S0165-0173(97)00021-0.
Poulia N, Delis F, Brakatselos C, Lekkas P, Kokras N, Dalla C, Antoniou K. Escalating low-dose Delta(9) -tetrahydrocannabinol exposure during adolescence induces differential behavioral and neurochemical effects in male and female adult rats. Eur J Neurosci. 2020;52:2681–2693. doi: 10.1111/ejn.14598.
Poulia N, Delis F, Brakatselos C, Polissidis A, Koutmani Y, Kokras N, Dalla C, Politis PK, Antoniou K. Detrimental effects of adolescent escalating low-dose Δ9-tetrahydrocannabinol leads to a specific bio-behavioural profile in adult male rats. Br J Pharmacol. 2021;178:1722–1736. doi: 10.1111/bph.15394.
Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA. Adolescent rats find repeated Δ9-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology. 2008;33:1113–1126. doi: 10.1038/sj.npp.1301475.
Randall PA, Nunes EJ, Janniere SL, Stopper CM, Farrar AM, Sager TN, Baqi Y, Hockemeyer J, Müller CE, Salamone JD. Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 2011;216:173–186. doi: 10.1007/s00213-011-2198-3.
Rasmussen EB, Huskinson SL. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats. Behav Pharmacol. 2008;19:735–742. doi: 10.1097/FBP.0b013e3283123cc2.
Realini N, Vigano D, Guidali C, Zamberletti E, Rubino T, Parolaro D. Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology. 2011;60:235–243. doi: 10.1016/j.neuropharm.2010.09.003.
Renard J, Krebs MO, Jay TM, Le Pen G. Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology. 2013;225:781–790. doi: 10.1007/s00213-012-2865-z.
Renard J, Vitalis T, Rame M, Krebs M-O, Lenkei Z, Le Pen G, Jay TM. Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex. Eur Neuropsychopharmacol. 2016;26:55–64. doi: 10.1016/j.euroneuro.2015.11.005.
Renard J, Rosen LG, Loureiro M, De Oliveira C, Schmid S, Rushlow WJ, Laviolette SR. Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex. Cereb Cortex. 2017;27:1297–1310. doi: 10.1093/cercor/bhv335.
Renteria R, Baltz ET, Gremel CM. Chronic alcohol exposure disrupts top-down control over basal ganglia action selection to produce habits. Nat Commun. 2018;9:211. doi: 10.1038/s41467-017-02615-9.
Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev. 1993;18:247–291. doi: 10.1016/0165-0173(93)90013-P.
Romero J, Garcia-Palomero E, Castro JG, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ. Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Mol Brain Res. 1997;46:100–108. doi: 10.1016/S0169-328X(96)00277-X.
Rouibi K, Contarino A. Increased motivation to eat in opiate-withdrawn mice. Psychopharmacology. 2012;221:675–684. doi: 10.1007/s00213-011-2612-x.
Rubino T, Vigano D, Realini N, Guidali C, Braida D, Capurro V, Castiglioni C, Cherubino F, Romualdi P, Candeletti S, Sala M, Parolaro D. Chronic Δ9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology. 2008;33:2760–2771. doi: 10.1038/sj.npp.1301664.
Rubino T, Prini P, Piscitelli F, Zamberletti E, Trusel M, Melis M, Sagheddu C, Ligresti A, Tonini R, Di Marzo V, Parolaro D. Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol Dis. 2015;73:60–69. doi: 10.1016/j.nbd.2014.09.015.
Ruiz CM, Torrens A, Castillo E, Perrone CR, Cevallos J, Inshishian VC, Harder EV, Justeson DN, Huestis MA, Swarup V, Piomelli D, Mahler SV. Pharmacokinetic, behavioral, and brain activity effects of Δ9-tetrahydrocannabinol in adolescent male and female rats. Neuropsychopharmacology. 2021;46:959–969. doi: 10.1038/s41386-020-00839-w.
Sallam NA, Borgland SL. Insulin and endocannabinoids in the mesolimbic system. J Neuroendocrinol. 2021;33:e12965. doi: 10.1111/jne.12965.
Sarne Y, Toledano R, Rachmany L, Sasson E, Doron R. Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol. Neurobiol Aging. 2018;61:177–186. doi: 10.1016/j.neurobiolaging.2017.09.025.
Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P. Adolescent Δ9-Tetrahydrocannabinol Exposure Alters WIN55,212–2 Self-Administration in Adult Rats. Neuropsychopharmacology. 2016;41:1416–1426. doi: 10.1038/npp.2015.295.
Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol. 2008;13:253–263. doi: 10.1111/j.1369-1600.2008.00110.x.
Schneider M, Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology. 2003;28:1760–1769. doi: 10.1038/sj.npp.1300225.
Schoch H, Huerta MY, Ruiz CM, Farrell MR, Jung KM, Huang JJ, Campbell RR, Piomelli D, Mahler SV. Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats. Psychopharmacology. 2018;235:121–134. doi: 10.1007/s00213-017-4749-8.
Silva L, Black R, Michaelides M, Hurd YL, Dow-Edwards D. Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: the unique susceptibility of the prepubescent animal. Neurotoxicol Teratol. 2016;58:88–100. doi: 10.1016/j.ntt.2016.02.005.
Sim-Selley LJ (2003) Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Critical Reviews™ in Neurobiology 15
Solinas M, Goldberg SR. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology. 2005;30:2035–2045. doi: 10.1038/sj.npp.1300720.
Solinas M, Panlilio LV, Goldberg SR. Exposure to Δ-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats. Neuropsychopharmacology. 2004;29:1301–1311. doi: 10.1038/sj.npp.1300431.
Spano MS, Ellgren M, Wang X, Hurd YL. Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol Psychiat. 2007;61:554–563. doi: 10.1016/j.biopsych.2006.03.073.
Spear LP. Consequences of adolescent use of alcohol and other drugs: studies using rodent models. Neurosci Biobehav Rev. 2016;70:228–243. doi: 10.1016/j.neubiorev.2016.07.026.
Steketee JD. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Rev. 2003;41:203–228. doi: 10.1016/S0165-0173(02)00233-3.
Stringfield SJ, Torregrossa MM. Disentangling the lasting effects of adolescent cannabinoid exposure. Prog Neuropsychopharmacol Biol Psychiatry. 2021;104:110067. doi: 10.1016/j.pnpbp.2020.110067.
Stringfield SJ, Torregrossa MM. Intravenous self-administration of delta-9-THC in adolescent rats produces long-lasting alterations in behavior and receptor protein expression. Psychopharmacology. 2021;238:305–319. doi: 10.1007/s00213-020-05684-9.
Suliman NA, Taib CNM, Moklas MAM, Basir R. Delta-9-tetrahydrocannabinol (∆ 9-THC) induce neurogenesis and improve cognitive performances of male Sprague Dawley rats. Neurotox Res. 2018;33:402–411. doi: 10.1007/s12640-017-9806-x.
Tomasiewicz HC, Jacobs MM, Wilkinson MB, Wilson SP, Nestler EJ, Hurd YL. Proenkephalin mediates the enduring effects of adolescent cannabis exposure associated with adult opiate vulnerability. Biol Psychiat. 2012;72:803–810. doi: 10.1016/j.biopsych.2012.04.026.
Torrens A, Vozella V, Huff H, McNeil B, Ahmed F, Ghidini A, Mahler SV, Huestis MA, Das A, Piomelli D. Comparative pharmacokinetics of Δ<sup>9</sup>-tetrahydrocannabinol in adolescent and adult male mice. J Pharmacol Exp Ther. 2020;374:151. doi: 10.1124/jpet.120.265892.
Turner KM, Parkes SL (2020) Prefrontal regulation of behavioural control: evidence from learning theory and translational approaches in rodents. Neurosci Biobehav Rev
Vela G, Martin S, La Garcia-Gil, Crespo JA, Ruiz-Gayo M, Fernandez-Ruiz JJ, Garcia-Lecumberri C, Pelaprat D, Fuentes JA, Ramos JA. Maternal exposure to Δ9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central μ opioid receptors in adult offspring female rats. Brain Res. 1998;807:101–109. doi: 10.1016/S0006-8993(98)00766-5.
Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MAP, Curran HV, Baler R. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. Jama Psychiat. 2016;73:292–297. doi: 10.1001/jamapsychiatry.2015.3278.
Ward SJ, Dykstra LA. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940) Behav Pharmacol. 2005;16:381–388. doi: 10.1097/00008877-200509000-00010.
Weed PF, Filipeanu CM, Ketchum MJ, Winsauer PJ. Chronic delta9-tetrahydrocannabinol during adolescence differentially modulates striatal CB1 receptor expression and the acute and chronic effects on learning in adult rats. J Pharmacol Exp Ther. 2016;356:20–31. doi: 10.1124/jpet.115.227181.
Weinstein G, Sznitman SR. The implications of late-life cannabis use on brain health: a mapping review and implications for future research. Ageing Res Rev. 2020;59:101041. doi: 10.1016/j.arr.2020.101041.
Wickens TD, Keppel G (2004) Design and analysis: a researcher's handbook. Pearson Prentice-Hall Upper Saddle River, NJ
Yu B, Chen X, Chen X, Yan H. Marijuana legalization and historical trends in marijuana use among US residents aged 12–25: results from the 1979–2016 National Survey on drug use and health. BMC Public Health. 2020;20:156. doi: 10.1186/s12889-020-8253-4.
Zamberletti E, Prini P, Speziali S, Gabaglio M, Solinas M, Parolaro D, Rubino T. Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. Neuroscience. 2012;204:245–257. doi: 10.1016/j.neuroscience.2011.11.038.

Associated Data

Supplementary Materials

Data Availability Statement

Data generated and analyzed during the current study will be made freely available from the corresponding authors upon request.

Studies

Conditions

Cannabinoids and active compounds

Related research

Abstract

Rationale

Objective and methods

Results

Conclusions

Supplementary Information

Untitled section

Article notes

Untitled section

Author notes

Introduction

Material and methods

Animals

Apparatus

Drug preparation and treatment

Experiment 1

Overview

Instrumental action-outcome training

Reward devaluation

Action-outcome reversal training and reward devaluation

Contingency degradation training and testing

Experiment 2

Overview

Hedonic feeding

Progressive ratio

Effects of rimonabant on progressive ratio performance

Data analysis

Results

Experiment 1

Bodyweight

Initial action-outcome training

Reward devaluation test

Action-outcome reversal training and reward devaluation

Contingency degradation training and testing

Experiment 2

Bodyweight

Hedonic feeding

Progressive ratio

Effects of rimonabant on progressive ratio performance

Discussion

Supplementary Information

Untitled section

Acknowledgements

Author contribution

Funding

Data Availability

Declarations

Conflict of interest

Footnotes

Footnote Group

Contributor Information

References

Untitled section

References

Associated Data

Supplementary Materials

Data Availability Statement

Additional materials